Pages that link to "Q37209166"
Jump to navigation
Jump to search
The following pages link to Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient (Q37209166):
Displaying 50 items.
- The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis (Q27004240) (← links)
- Ageing and Parkinson's disease: why is advancing age the biggest risk factor? (Q27021628) (← links)
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies (Q27686837) (← links)
- Alpha-synuclein and tau: teammates in neurodegeneration? (Q28250508) (← links)
- Evaluation of alpha-synuclein immunohistochemical methods used by invited experts (Q30488694) (← links)
- Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. (Q30493972) (← links)
- Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults. (Q30506492) (← links)
- GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology (Q30527838) (← links)
- Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions (Q33556006) (← links)
- Blood pressure and brain injury in older adults: findings from a community-based autopsy study. (Q33637739) (← links)
- Association between lifetime cigarette smoking and lewy body accumulation (Q33829013) (← links)
- Pathologic correlates of dementia in individuals with Lewy body disease (Q33896668) (← links)
- Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium (Q34023599) (← links)
- National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (Q34635272) (← links)
- Familial prion disease with alzheimer disease‐like tau pathology and clinical phenotype (Q35043994) (← links)
- White matter lesions defined by diffusion tensor imaging in older adults (Q35224243) (← links)
- Ecology of the aging human brain (Q35556875) (← links)
- Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old (Q35606753) (← links)
- A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics (Q35924508) (← links)
- Multiple pathologies are common and related to dementia in the oldest-old: The 90 Study (Q35966448) (← links)
- Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies? (Q36004679) (← links)
- Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology (Q36581696) (← links)
- APOE ε4 increases risk for dementia in pure synucleinopathies (Q36634159) (← links)
- Altered Proteins in the Aging Brain (Q36692073) (← links)
- Lewy body pathology in normal elderly subjects (Q37246606) (← links)
- Visual hallucinations in dementia: a prospective community-based study with autopsy (Q37343136) (← links)
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction (Q37376010) (← links)
- Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies (Q37393410) (← links)
- Cognitive impairment in older adults without dementia: clinical and pathologic outcomes in a community-based sample (Q37438087) (← links)
- Formation and development of Lewy pathology: a critical update (Q37587790) (← links)
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria (Q37631959) (← links)
- Milestones in Parkinson's disease--clinical and pathologic features (Q37882587) (← links)
- Neuropathology underlying clinical variability in patients with synucleinopathies (Q37896515) (← links)
- Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts (Q37955871) (← links)
- The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders (Q38012653) (← links)
- The function of α-synuclein (Q38139561) (← links)
- Staged pathology in Parkinson's disease (Q38164891) (← links)
- Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein (Q38669105) (← links)
- Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85 Study. (Q38797714) (← links)
- Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease. (Q38848617) (← links)
- Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes. (Q45232246) (← links)
- The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases (Q46251905) (← links)
- Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. (Q48287129) (← links)
- Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies (Q48575031) (← links)
- APOE DNA methylation is altered in Lewy body dementia (Q51739639) (← links)
- Risk factors of hippocampal sclerosis in the oldest old: The 90 Study (Q57472031) (← links)
- Dementia with Lewy bodies: an update and outlook (Q61446034) (← links)
- Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders (Q64759312) (← links)
- Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but 'failure to fit' is highly dependent on staging system applied (Q64769163) (← links)
- The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders. (Q64814715) (← links)